{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:51:18Z","timestamp":1787003478889,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T00:00:00Z","timestamp":1589932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Background and Aims: Body mass index (BMI) is known to be closely related to the prognosis and mortality of various diseases. The aim of our study was to evaluate differences in post-treatment overall survival (OS) according to BMI with hepatocellular carcinoma (HCC) and to understand the meaning of BMI. Among the records of 10,578 HCC patients registered at the Korean Central Cancer Registry from 2008 through 2014, we selected Barcelona Clinic Liver Cancer (BCLC) 0, A, and B staged HCC patients (n\u2009=\u20094,926). HCC patients showed a good prognosis in the order of overweight, normal weight, obesity, and underweight. However, comparing normal-weight (BMI 18.5\u201324.9\u2009kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    ) to overweight (BMI 25\u201329.9\u2009kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    ) after propensity score matching (PSM), there was no significant difference in OS (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.153). Overweight males had a better prognosis than normal-weight males (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.014), but, normal-weight females had a better prognosis than overweight. To determine the gender-specific OS differences, we examined the differences according to the HCC treatment type. In males, overweight patients had better OS after transarterial chemoembolization (TACE) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.039) than normal-weight, but not after surgical resection (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.618) nor radiofrequency ablation (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.553). However, in females, all of those HCC treatments resulted in significantly better OS in normal-weight patients than overweight. In patients with HCC of BCLC stages 0\u2013B, unlike females, overweight males had a better prognosis than normal-weight, especially among TACE-treated patients. Our results carefully suggest that the meaning of normal BMI in patients with HCC may have gender difference.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-65460-9","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T06:02:32Z","timestamp":1589954552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database"],"prefix":"10.1038","volume":"10","author":[{"given":"Boram","family":"Cha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Joo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ju","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,20]]},"reference":[{"key":"65460_CR1","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1200\/JCO.2015.64.7412","volume":"34","author":"JL Petrick","year":"2016","unstructured":"Petrick, J. L., Kelly, S. P., Altekruse, S. F., McGlynn, K. A. & Rosenberg, P. S. Future of hepatocelluar carcinoma incidence in the United States forecast through 2030. J. Clin. Oncol. 34, 1787\u20131794 (2016).","journal-title":"J. Clin. Oncol."},{"key":"65460_CR2","doi-asserted-by":"publisher","unstructured":"National Cancer Policy Forum, Board on Health Care Services, Patlak, M. & Nass, S. J. The Role of Obesity in Cancer Survival and Recurrence: Workshop Summary. Cancer Epidemiol Biomarkers Prev. 1\u201328, https:\/\/doi.org\/10.1158\/1055-9965.EPI-12-0485.The (2013).","DOI":"10.1158\/1055-9965.EPI-12-0485.The"},{"key":"65460_CR3","doi-asserted-by":"crossref","unstructured":"Sun, L., Zhu, Y., Qian, Q. & Tang, L. Body mass index and prognosis of breast cancer. Med. (United States) 97 (2018).","DOI":"10.1097\/MD.0000000000011220"},{"key":"65460_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/jamaoncol.2016.0732","volume":"2","author":"CH Kroenke","year":"2016","unstructured":"Kroenke, C. H. et al. Analysis of body mass index and mortality in patients with colorectal cancer using causal diagrams. JAMA Oncol. 2, 1137\u20131145 (2016).","journal-title":"JAMA Oncol."},{"key":"65460_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijsu.2016.04.049","volume":"30","author":"N Yabusaki","year":"2016","unstructured":"Yabusaki, N. et al. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection. Int. J. Surg. 30, 136\u2013142 (2016).","journal-title":"Int. J. Surg."},{"key":"65460_CR6","first-page":"370","volume":"17","author":"W-H Pan","year":"2008","unstructured":"Pan, W.-H. & Yeh, W.-T. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac. J. Clin. Nutr. 17, 370\u20134 (2008).","journal-title":"J. Clin. Nutr."},{"key":"65460_CR7","unstructured":"WORLD CANCER RESEARCH FUND. Food, Nutrition, Physical Activity, and the Prevention of Cancer. Am. Inst. Cancer Res. (AICR); World Cancer Res. Fund (WCRF UK) World Cancer Res. Fund Int. (2007)."},{"key":"65460_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2018.0037","volume":"25","author":"JJ Yoo","year":"2019","unstructured":"Yoo, J. J. et al. Recent research trends and updates on nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 25, 1\u201311 (2019).","journal-title":"Clin. Mol. Hepatol."},{"key":"65460_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1146\/annurev-nutr-071811-150713","volume":"32","author":"N Parekh","year":"2012","unstructured":"Parekh, N., Chandran, U. & Bandera, E. V. Obesity in Cancer Survival. Annu. Rev. Nutr. 32, 311\u2013342 (2012).","journal-title":"Annu. Rev. Nutr."},{"key":"65460_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/cam4.634","volume":"5","author":"NM Tsang","year":"2016","unstructured":"Tsang, N. M. et al. Overweight and obesity predict better overall survival rates in cancer patients with distant metastases. Cancer Med. 5, 665\u2013675 (2016).","journal-title":"Cancer Med."},{"key":"65460_CR11","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1038\/ijo.2008.87","volume":"32","author":"K Rothman","year":"2008","unstructured":"Rothman, K. BMI-related errors in the measurement of obesity. Int. J. Obes. 32, S56\u2013S59 (2008).","journal-title":"Int. J. Obes."},{"key":"65460_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3109\/03014460.2011.606832","volume":"38","author":"AM Nevill","year":"2011","unstructured":"Nevill, A. M. et al. Inverted BMI rather than BMI is a better proxy for percentage of body fat. Ann. Hum. Biol. 38, 681\u2013684 (2011).","journal-title":"Ann. Hum. Biol."},{"key":"65460_CR13","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1038\/nutd.2015.36","volume":"5","author":"AM Nevill","year":"2015","unstructured":"Nevill, A. M. & Metsios, G. S. The need to redefine age- and gender-specific overweight and obese body mass index cutoff points. Nutr. Diabetes 5, e186\u20132 (2015).","journal-title":"Nutr. Diabetes"},{"key":"65460_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/oby.2010.248","volume":"19","author":"M Sarah","year":"2011","unstructured":"Sarah, M. et al. The Relationship of Waist Circumference and BMI to Visceral, Subcutaneous, and Total Body Fat: Sex and Race Differences. Obesity 19, 402\u2013408 (2011).","journal-title":"Obesity"},{"key":"65460_CR15","doi-asserted-by":"crossref","unstructured":"Imai, K. et al. Sarcopenia impairs prognosis of patients with hepatocellular carcinoma: The role of liver functional reserve and tumor-related factors in loss of skeletal muscle volume. Nutrients 9 (2017).","DOI":"10.3390\/nu9101054"},{"key":"65460_CR16","doi-asserted-by":"publisher","first-page":"9612","DOI":"10.3390\/ijms16059612","volume":"16","author":"K Imai","year":"2015","unstructured":"Imai, K. et al. Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib. Int. J. Mol. Sci. 16, 9612\u20139624 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"65460_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nut.2014.07.005","volume":"31","author":"T Hanai","year":"2015","unstructured":"Hanai, T. et al. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition 31, 193\u2013199 (2015).","journal-title":"Nutrition"},{"key":"65460_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/hepr.12616","volume":"46","author":"T Hanai","year":"2016","unstructured":"Hanai, T. et al. Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis. Hepatol. Res. 46, 743\u2013751 (2016).","journal-title":"Hepatol. Res."},{"key":"65460_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3350\/cmh.2017.0077","volume":"24","author":"DH Gu","year":"2018","unstructured":"Gu, D. H. et al. Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis. Clin. Mol. Hepatol. 24, 319\u2013330 (2018).","journal-title":"Clin. Mol. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65460-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:56:41Z","timestamp":1670309801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65460-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65460"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65460-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"17 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8347"}}